Consolidated Portfolio Review Corp’s iShares iBonds Dec 2027 Term Treasury ETF IBTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-45,267
Closed -$1.02M 204
2025
Q3
$1.02M Buy
45,267
+2,720
+6% +$61.1K 0.13% 174
2025
Q2
$957K Buy
42,547
+3,274
+8% +$73.3K 0.13% 173
2025
Q1
$880K Buy
39,273
+4,543
+13% +$101K 0.14% 165
2024
Q4
$771K Buy
34,730
+5,836
+20% +$130K 0.12% 182
2024
Q3
$654K Buy
28,894
+1,722
+6% +$38.6K 0.15% 163
2024
Q2
$600K Buy
27,172
+4,063
+18% +$89.3K 0.14% 167
2024
Q1
$512K Buy
+23,109
New +$514K 0.13% 157

Other funds holding IBTH

Consolidated Portfolio Review Corp's IBTH Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of iShares iBonds Dec 2027 Term Treasury ETF (IBTH) in Q4 2025, closing a stake of 45,267 shares — an estimated $1.02M sold.

Consolidated Portfolio Review Corp first reported a position in IBTH in Q1 2024 and held it in 7 quarters. The position peaked at $1.02M in Q3 2025. 300 funds tracked by Wall St. Rank hold IBTH as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining iShares iBonds Dec 2027 Term Treasury ETF position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 45,267 iShares iBonds Dec 2027 Term Treasury ETF shares in Q4 2025, an estimated $1.02M.
  • Consolidated Portfolio Review Corp first reported a position in iShares iBonds Dec 2027 Term Treasury ETF in Q1 2024 and held it in 7 quarters.
  • Consolidated Portfolio Review Corp's iShares iBonds Dec 2027 Term Treasury ETF position peaked at $1.02M in Q3 2025.
  • 300 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Treasury ETF as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.